Immutep Ltd (IMM) - Total Liabilities

Latest as of June 2025: AU$13.35 Million AUD ≈ $9.44 Million USD

Based on the latest financial reports, Immutep Ltd (IMM) has total liabilities worth AU$13.35 Million AUD (≈ $9.44 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Immutep Ltd to evaluate the company's liquid asset resilience ratio.

Immutep Ltd - Total Liabilities Trend (2000–2025)

This chart illustrates how Immutep Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see IMM total asset value.

Immutep Ltd Competitors by Total Liabilities

The table below lists competitors of Immutep Ltd ranked by their total liabilities.

Company Country Total Liabilities
Lake Victoria Gold Ltd.
V:LVG
Canada CA$4.53 Million
Space Com
TA:SCC
Israel ILA174.75 Million
Koan Hao Technology Co Ltd
TWO:8354
Taiwan NT$2.13 Billion
LTKM Bhd
KLSE:7085
Malaysia RM78.33 Million
Diginex Limited Ordinary Shares
NASDAQ:DGNX
USA $32.01 Million
ALANDEQGRP FPO
AU:AEG
Australia AU$3.09 Million
Componenta Corp
HE:CTH1V
Finland €41.17 Million
JP Morgan Global Growth & Income PLC
LSE:JGGI
UK GBX151.54 Million

Liability Composition Analysis (2000–2025)

This chart breaks down Immutep Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See IMM net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 11.69 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 1.35 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.09 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.09 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Immutep Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Immutep Ltd (2000–2025)

The table below shows the annual total liabilities of Immutep Ltd from 2000 to 2025.

Year Total Liabilities Change
2025-06-30 AU$13.35 Million
≈ $9.44 Million
+10.70%
2024-06-30 AU$12.06 Million
≈ $8.53 Million
+9.82%
2023-06-30 AU$10.98 Million
≈ $7.77 Million
+35.68%
2022-06-30 AU$8.09 Million
≈ $5.73 Million
-7.61%
2021-06-30 AU$8.76 Million
≈ $6.20 Million
-34.13%
2020-06-30 AU$13.30 Million
≈ $9.41 Million
-17.68%
2019-06-30 AU$16.15 Million
≈ $11.43 Million
+19.86%
2018-06-30 AU$13.48 Million
≈ $9.54 Million
+59.84%
2017-06-30 AU$8.43 Million
≈ $5.97 Million
+16.51%
2016-06-30 AU$7.24 Million
≈ $5.12 Million
+14.98%
2015-06-30 AU$6.29 Million
≈ $4.45 Million
+125.93%
2014-06-30 AU$2.79 Million
≈ $1.97 Million
-21.88%
2013-06-30 AU$3.57 Million
≈ $2.52 Million
-19.95%
2012-06-30 AU$4.45 Million
≈ $3.15 Million
+75.28%
2011-06-30 AU$2.54 Million
≈ $1.80 Million
+14.29%
2010-06-30 AU$2.22 Million
≈ $1.57 Million
+228.41%
2009-06-30 AU$677.10K
≈ $479.09K
+260.51%
2008-06-30 AU$187.82K
≈ $132.89K
-32.49%
2007-06-30 AU$278.21K
≈ $196.85K
-73.33%
2006-06-30 AU$1.04 Million
≈ $738.22K
+32.38%
2005-06-30 AU$788.11K
≈ $557.64K
+22.76%
2004-06-30 AU$642.00K
≈ $454.26K
-26.63%
2003-06-30 AU$875.00K
≈ $619.12K
+87.77%
2002-06-30 AU$466.00K
≈ $329.72K
+356.86%
2001-06-30 AU$102.00K
≈ $72.17K
-53.42%
2000-06-30 AU$219.00K
≈ $154.96K
--

About Immutep Ltd

AU:IMM Australia Biotechnology
Market Cap
$41.66 Million
AU$58.88 Million AUD
Market Cap Rank
#22677 Global
#820 in Australia
Share Price
AU$0.04
Change (1 day)
+5.26%
52-Week Range
AU$0.04 - AU$0.46
All Time High
AU$0.68
About

Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on LAG-3 immune control mechanism for the treatment of different types of cancers. The company's product pipeline also includes… Read more